| Stephen Spencer Burnside, MD | |
|
1818 E Rezanof Dr, Kodiak, AK 99615 | |
| (907) 486-6065 | |
| (907) 486-2248 |
| Full Name | Stephen Spencer Burnside |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 1818 E Rezanof Dr, Kodiak, Alaska |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225004401 | NPI | - | NPPES |
| 920088665 | Other | AK | EMPLOYEE ID |
| GR0173 | Medicaid | AK | |
| MD 03803 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | AA2876 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Kodiak Island Medical Ctr | Kodiak, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kodiak Island Health Care Foundation | 8022922509 | 14 |
| Providence Health And Services Washington | 5799675120 | 15 |
News Archive
Obesity and excess weight, and their negative impact on health, have become a significant focus for physicians and other health-care experts in recent years.
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
Sepsis is a life-threatening complication of infection in which the molecules that the body releases to fight an infection trigger widespread inflammatory responses, resulting in damage to multiple organ systems.
› Verified 9 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952430902 PECOS PAC ID: 5799675120 Enrollment ID: O20040318000605 |
News Archive
Obesity and excess weight, and their negative impact on health, have become a significant focus for physicians and other health-care experts in recent years.
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
Sepsis is a life-threatening complication of infection in which the molecules that the body releases to fight an infection trigger widespread inflammatory responses, resulting in damage to multiple organ systems.
› Verified 9 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1013905660 PECOS PAC ID: 5799675120 Enrollment ID: O20041221000920 |
News Archive
Obesity and excess weight, and their negative impact on health, have become a significant focus for physicians and other health-care experts in recent years.
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
Sepsis is a life-threatening complication of infection in which the molecules that the body releases to fight an infection trigger widespread inflammatory responses, resulting in damage to multiple organ systems.
› Verified 9 days ago
| Entity Name | Kodiak Island Health Care Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326047044 PECOS PAC ID: 8022922509 Enrollment ID: O20090428000439 |
News Archive
Obesity and excess weight, and their negative impact on health, have become a significant focus for physicians and other health-care experts in recent years.
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
Sepsis is a life-threatening complication of infection in which the molecules that the body releases to fight an infection trigger widespread inflammatory responses, resulting in damage to multiple organ systems.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Spencer Burnside, MD 1818 E Rezanof Dr, Kodiak, AK 99615 Ph: (907) 486-6065 | Stephen Spencer Burnside, MD 1818 E Rezanof Dr, Kodiak, AK 99615 Ph: (907) 486-6065 |
News Archive
Obesity and excess weight, and their negative impact on health, have become a significant focus for physicians and other health-care experts in recent years.
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
Sepsis is a life-threatening complication of infection in which the molecules that the body releases to fight an infection trigger widespread inflammatory responses, resulting in damage to multiple organ systems.
› Verified 9 days ago
Carol Juergens, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1818 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-6065 Fax: 907-486-2248 |